Viral respiratory infections such as those caused by influenza can drive a dangerous inflammatory immune response that damages the lungs. Some viruses induce lung fibroblasts to produce factors that enhance inflammation and protein degradation, reducing lung function. Understanding how to control this immune response is crucial, as it may enhance patient survival after viral infection.
In this webinar sponsored by 10x Genomics, Paul Thomas from St. Jude Children’s Research Hospital will discuss how his team discovered the cellular and molecular mechanisms underlying virus induced lung damage using single cell and spatial transcriptomics. He will also discuss plans to translate these findings into treatments for preserving lung function and improving patient survival.
Topics to be covered
Cell-mediated inflammation in the lungs following respiratory infection, including fibroblasts as the gatekeepers of the inflammatory immune response
How spatial architecture influences fibroblast activation and disease severity in the lungs
The role of ADAMTS-4, an enzyme implicated in driving inflammation and lung damage
Small molecule treatments to inhibit ADAMTS-4
Thursday, March 18, 2021
12:00 - 1:00 PM Eastern Time
Meet the speaker
Paul G. Thomas, PhD Member, St. Jude Faculty
Sponsored by
Register Now
Understanding Immune-Mediated Damage After Respiratory Infection March 16, 2021
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
